Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells

NCT04572308 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

T-cell Acute Lymphoblastic Leukemia/Lymphoma

Interventions

BIOLOGICAL: CD7 CAR-T

Sponsor

Hebei Senlang Biotechnology Inc., Ltd.